Dr. Elizabeth Griffiths earned her medical degree at the University of North Carolina School of Medicine, Chapel Hill. She completed a five-year medical oncology and hematology fellowship at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital in Baltimore, where she also completed her internal medicine residency. She is an Associate Professor at the State University of New York (SUNY) at Buffalo and a faculty member of the Roswell Park Comprehensive Cancer Center-SUNY Buffalo graduate training programs in the Departments of Pharmacology and Therapeutics, Translational Medicine and Immunology.

Dr. Griffiths is board certified in hematology, oncology, and internal medicine. She is a member of the American Society of Hematology (ASH), the American Association for Cancer Research, the Society for Immunotherapy of Cancer, and the American Society of Oncology. Dr. Griffiths treats patients with blood disorders, specifically acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), as well as bone marrow failure syndromes, such as aplastic anemia and myelodysplastic syndrome (MDS). Her research is focused on the mechanism of hypomethylating agents (HMAs) in patients with myeloid cancer, specifically the contribution of the immune system to these responses.